Amber is part of the Preclinical Development team at Life Edit Therapeutics. She is primarily focused on in vivo work, as well as the development and generation of associated protocols and reports.

Prior to joining Life Edit, Amber was an associate scientist at Carisma Therapeutics, where she worked on the development and implementation of cell therapy driven in vivo platforms. She has 6+ years working with various animal models, with an extensive research background in the fields of neuroscience, oncology, endocrinology, and immunology.

Amber received her M.S. degree at Saint Joseph’s University in Philadelphia, where she studied experimental psychology and neuroendocrinology, and received her B.A. from Chestnut Hill College.